Cell Harvesting System Market Eyes 2.2x Expansion by 2032 - Insights from Persistence Market Research

The global cell harvesting system market is experiencing a transformative phase, fueled by rapid advancements in automation, rising demand for regenerative medicine, and the increasing adoption of personalized therapies. As per recent findings from Persistence Market Research, the market is expected to surge from US$ 6.9 Bn in 2025 to US$ 15.5 Bn by 2032, registering a robust CAGR of 12.2% during the forecast period.

Cell harvesting plays a pivotal role in biologics manufacturing by isolating target cells from the growth medium. Initially reliant on manual methods like centrifugation and depth filtration, the process has now embraced automation to improve throughput, consistency, and precision. This shift is driven by increasing R&D in cell-based treatments, integration of AI-driven platforms, and growing infrastructure in life sciences.

Automated systems are set to dominate the market with a projected 67.4% market share in 2025, largely due to their efficiency, reduced contamination risks, and high scalability. North America leads the global landscape with an estimated 38.6% market value share, driven by advanced biopharmaceutical capabilities, robust funding, and strong academic-industry collaborations.

✅Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/34752

✅Key Highlights from the Report:

➤ Automated systems are projected to account for 67.4% of market revenue in 2025, replacing legacy manual methods.
➤ The cell harvesting system market is driven by the growing need for regenerative medicine and stem cell therapies.
➤ Innovations like automated filtration and closed-loop systems are transforming biomanufacturing efficiency.
➤ Biopharmaceutical applications lead the market due to rising personalized and cell-based treatment demand.
➤ North America dominates with 38.6% share, supported by cutting-edge R&D infrastructure and funding.
➤ Asia Pacific sees strong growth fueled by government investments and biotech ecosystem expansion.

✅Market Segmentation: Product Types and End-User Applications

The cell harvesting system market is broadly segmented by product types, including manual systems, automated systems, and semi-automated systems. Among these, automated systems are gaining the lion's share of demand. With their precision, lower risk of contamination, and ability to support continuous processing, these systems are vital in modern biomanufacturing. Manual systems, though cost-effective, are increasingly phased out due to scalability and reproducibility limitations.

In terms of end-user segmentation, the market is led by biopharmaceutical companies, research laboratories, and academic institutes. Biopharmaceutical firms hold the highest market share due to their significant investments in biologics and advanced therapies. Research institutions are also key contributors, driven by increased clinical trials and innovation in cell-based diagnostics and treatments. Academic institutes facilitate early-stage research, often collaborating with commercial firms to bridge discovery and application.

✅Regional Insights

North America stands at the forefront of the global market, holding a commanding 38.6% share in 2025. This dominance is underpinned by a mature biopharma industry, aggressive R&D funding, and a robust regulatory framework that supports novel technologies.

Europe, bolstered by favorable regulatory environments and state-backed research funding, continues to be a strong contributor to market growth. Initiatives such as Collaborative Research Centres (CRCs) and GMP-ready facilities boost adoption of cell harvesting systems across the region.

✅Market Drivers

The core growth driver of the cell harvesting system market is the shift toward automation and innovation. Modern systems like automated tangential flow filtration (TFF), single-use centrifuges, and robotic platforms enable sterile processing, reduce waste, and accelerate production timelines. Companies such as Thermo Fisher Scientific and Cytiva have introduced integrated platforms that align with FDA's vision for future-ready biologics manufacturing.

Additionally, the rise in regenerative medicine and stem cell therapies calls for high-throughput, precision cell harvesting systems. These treatments, targeting chronic diseases and personalized conditions, are largely dependent on scalable cell processing technologies.

✅Market Restraints

Despite promising growth, the market faces several challenges that restrain adoption, especially in developing and legacy facilities. The high cost of automated systems and the complex qualification process are key hurdles. Transitioning from manual to automated workflows requires significant investment, process validation, and staff retraining.

Moreover, many facilities still prefer older systems due to regulatory familiarity and existing infrastructure. Inconsistent implementation across regions hampers uniform adoption, affecting the economies of scale required to make automation more affordable.

✅Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/34752

✅Market Opportunities

The emergence of novel cell harvesting platforms and automation solutions is opening new doors for innovation in the biomanufacturing and regenerative medicine landscape. Innovations such as AI-integrated robotic arms, 3D-printed microfluidics, and dissolvable microcarriers enable more efficient, sterile, and scalable cell harvesting.

These technologies reduce contamination risks, minimize manual handling, and support continuous monitoring-making them ideal for the production of stem cells, CAR-T therapies, and tissue-engineered products. Strategic partnerships between startups and established firms further expand global reach and innovation potential.

✅Reasons to Buy the Report:
✔ Gain in-depth market insights with accurate forecasting from 2025 to 2032.
✔ Identify high-growth segments and regions to optimize investment strategies.
✔ Understand emerging technologies transforming the cell harvesting process.
✔ Benchmark top players and recent developments to stay ahead in the market.
✔ Access detailed segmentation by product type, application, and geography.

✅Company Insights

Key players driving innovation and competition in the global market include:

✦ Thermo Fisher Scientific Inc.
✦ Cytiva (Danaher)
✦ Esco Micro Pte. Ltd.
✦ Sartorius AG
✦ Beckman Coulter, Inc
✦ Dr. Mueller AG
✦ PerkinElmer / Revvity
✦ Smart MCs PTY LTD
✦ Corning Incorporated
✦ Technical Proteins Nanobiotechnology
✦ ScaleReady USA
✦ CARR Biosystems
✦ SINFONIA TECHNOLOGY CO., LTD.
✦ Cole-Parmer Instrument Company, LLC
✦ Human Med
✦ ADS Biotec Inc.
✦ Akadeum Life Sciences
✦ AVITA Medical

✅Recent Developments:

In June 2025, Sphere Fluidics introduced Cyto?Mine Chroma, enhancing multiplexed single-cell analysis and automated harvesting for biopharmaceutical workflows.

In December 2024, Ori Biotech Ltd. partnered with Fresenius Kabi to integrate cell therapy systems, streamlining closed-loop bioprocessing for CAR-T therapies.

✅Final Thoughts

The cell harvesting system market is entering a golden era of innovation and scalability. Backed by strong investments in biotechnology, increasing focus on precision medicine, and the adoption of advanced automated systems, the market is expected to more than double by 2032.

However, stakeholders must navigate cost-related barriers and integration challenges. Players that align with technological innovation, offer scalable solutions, and forge strategic partnerships will be best positioned to capitalize on the future of biologics manufacturing and regenerative medicine. According to Persistence Market Research, the next decade will see cell harvesting evolve from a laboratory task to a central pillar of modern healthcare solutions.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.